Tokyo, April 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061112) titled 'Comparison of postoperative analgesia between interscalene and supraclavicu... Read More
Tokyo, April 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061149) titled 'Nationwide multicenter retrospective study of mesh infection after inguinal... Read More
Tokyo, April 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061167) titled 'Safety Evaluation of Long-term Intake of a Probiotic food: A Randomized, Do... Read More
Tokyo, April 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061168) titled 'Longitudinal study of brain synaptic function and symptom changes in neurol... Read More
Tokyo, April 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061171) titled 'Evaluation of 0.3% Motugivatrep Ophthalmic Suspension on Visual Function an... Read More
Tokyo, April 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061169) titled 'Development and Evaluation of a Participatory Program for Building Workplac... Read More
Tokyo, April 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061172) titled 'Development and Evaluation of a Nursing Educational Program on Vascular Acc... Read More
Singapore, April 5 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More
Singapore, April 5 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More
Singapore, April 5 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More